KIDNEY-SPARING

Clinical trials for KIDNEY-SPARING explained in plain language.

Never miss a new study

Get alerted when new KIDNEY-SPARING trials appear

Sign up with your email to follow new studies for KIDNEY-SPARING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo may treat kidney cancer without removing the organ

Disease control Recruiting now

This study tests whether a combination of two drugs (tislelizumab and nab-paclitaxel) can treat renal pelvic cancer while avoiding removal of the kidney. About 35 adults with early-stage cancer that hasn't spread will receive the drugs, and if the tumor shrinks enough, they may g…

Matched conditions: KIDNEY-SPARING

Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control

Last updated May 26, 2026 10:34 UTC

KIDNEY-SPARING

Get alerted when new KIDNEY-SPARING trials appear

New combo may treat kidney cancer without removing the organ